ADVFN ADVFN

Hot Features

Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Revvity Inc

Revvity Inc (RVTY)

112,95
-0,81
(-0,71%)
Fermé 07 Juillet 10:00PM
112,95
0,00
(0,00%)
Après les heures de négociation: 11:01PM

Revvity Inc (RVTY) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
112,95
( -0,71% )
Prix Achat
-
Prix Vente
-
Volume échangé
1 006 266
111,02 Fourchette du Jour 113,03
81,22 Plage de 52 semaines 118,2999
Cap du marché
Clôture Veille
113,76
Ouverture
112,88
Dernière Transaction
340387
@
112.95
Dernière heure de transaction
Volume financier
US$ 112 922 808
VWAP
112,2196
Volume moyen (3 m)
US$ 1 431 708
Actions en circulation
111 559 773
Rendement du Dividende (LTM)
0,28 (0,29%)
Ratio Cours sur Bénéfices
54,46
Bénéfice par action (BPA)
2,1
Chiffre d'affairess (LTM)
2,9B
Bénéfice net (LTM)
239,68M

À propos de Revvity Inc

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early ... Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Site Web
Siège social
Waltham, United States
Fondé
2026
Revvity Inc est coté dans le secteur Healthcare de la New York Stock Exchange avec le ticker RVTY. Le dernier cours de clôture d'Revvity était de US$113,76. Au cours de la dernière année, les actions de Revvity ont été négociées dans une fourchette de prix de US$ 81,22 à US$ 118,2999.

Revvity compte actuellement 111 559 773 actions en circulation. La capitalisation boursière d'Revvity est de US$12,60 milliard. Revvity a un ratio cours/bénéfice (ratio PE) de 54.46.

RVTY Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.63-0.554675118859113.58115.63109.621734921111.92277728CS
412.8412.8258915193100.11116.1696.8551578815106.26540598CS
1223.6826.526268623389.27116.1681.22148206299.0375078CS
2611.6511.5004935834101.3118.299981.22138162899.4419471CS
5212.0711.9647105472100.88118.299981.22136796396.64982748CS
156-2.75-2.3768366465115.713279.51054125102.83300332CS
260-3.39-2.91387313048116.3413279.51044256103.2962821CS

RVTY - Frequently Asked Questions (FAQ)

What is the current Revvity Inc share price?
The current share price of Revvity Inc is US$ 112,95
How many Revvity Inc shares are in issue?
Revvity Inc has 111 559 773 shares in issue
What is the market cap of Revvity Inc?
The market capitalisation of Revvity Inc is USD 12,6B
What is the 1 year trading range for Revvity Inc share price?
Revvity Inc has traded in the range of US$ 81,22 to US$ 118,2999 during the past year
What is the PE ratio of Revvity Inc?
The price to earnings ratio of Revvity Inc is 54,46
What is the cash to sales ratio of Revvity Inc?
The cash to sales ratio of Revvity Inc is 4,37
What is the registered address of Revvity Inc?
The registered address for Revvity Inc is 77 4th Avenue, Waltham, Massachusetts, 02451
What is the Revvity Inc website address?
The website address for Revvity Inc is www.revvity.com
Which industry sector does Revvity Inc operate in?
Revvity Inc operates in the Biotechnology & Life Sciences sector

RVTY Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock